An updated review on drug‐induced cholestasis: Mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. Issue 9 (7th May 2013)
- Record Type:
- Journal Article
- Title:
- An updated review on drug‐induced cholestasis: Mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. Issue 9 (7th May 2013)
- Main Title:
- An updated review on drug‐induced cholestasis: Mechanisms and investigation of physicochemical properties and pharmacokinetic parameters
- Authors:
- Yang, Kyunghee
Köck, Kathleen
Sedykh, Alexander
Tropsha, Alexander
Brouwer, Kim L. R.
Nakashima, Emi
Brouwer, Kim
Hammarlund‐Udenaes, Margareta
Terasaki, Tetsuya - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Drug‐induced cholestasis is an important form of acquired liver disease and is associated with significant morbidity and mortality. Bile acids are key signaling molecules, but they can exert toxic responses when they accumulate in hepatocytes. This review focuses on the physiological mechanisms of drug‐induced cholestasis associated with altered bile acid homeostasis due to direct (e.g., bile acid transporter inhibition) or indirect (e.g., activation of nuclear receptors, altered function/expression of bile acid transporters) processes. Mechanistic information about the effects of a drug on bile acid homeostasis is important when evaluating the cholestatic potential of a compound, but experimental data often are not available. The relationship between physicochemical properties, pharmacokinetic parameters, and inhibition of the bile salt export pump among 77 cholestatic drugs with different pathophysiological mechanisms of cholestasis (i.e., impaired formation of bile vs. physical obstruction of bile flow) was investigated. The utility of <italic>in silico</italic> models to obtain mechanistic information about the impact of compounds on bile acid homeostasis to aid in predicting the cholestatic potential of drugs is highlighted. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:3037–3057, 2013</p> </abstract>
- Is Part Of:
- Journal of pharmaceutical sciences. Volume 102:Issue 9(2013:Sep.)
- Journal:
- Journal of pharmaceutical sciences
- Issue:
- Volume 102:Issue 9(2013:Sep.)
- Issue Display:
- Volume 102, Issue 9 (2013)
- Year:
- 2013
- Volume:
- 102
- Issue:
- 9
- Issue Sort Value:
- 2013-0102-0009-0000
- Page Start:
- 3037
- Page End:
- 3057
- Publication Date:
- 2013-05-07
- Subjects:
- Pharmacy -- Periodicals
615.1 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-6017 ↗
http://www.jpharmsci.org/issues ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jps.23584 ↗
- Languages:
- English
- ISSNs:
- 0022-3549
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5031.900000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3000.xml